Image
Practice Point
Assessment of markers after neoadjuvant therapy
Repeat receptor status testing on any residual disease after neoadjuvant systemic therapy.
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.
Assessment of markers after neoadjuvant therapy
Practice Point
Repeat receptor status testing on any residual disease after neoadjuvant systemic therapy.
Principles in action
Safe and quality care
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.